Tags: APA
Dr. David Dadiomov, a board certified psychiatric pharmacist with a doctorate in pharmacy and residency training in psychiatric pharmacy, shares his clinical expertise to provide detailed information about the range of common medications prescribed for mental health conditions. You will get the latest information on antidepressants, anxiolytics, and common medications for insomnia and attention deficit/hyperactivity disorder among others. Through lecture, the examination of multi-disciplinary ethics codes and real case examples, you will take a close look at the ethical decisions that accompany medication use and the non-prescribers role and limits with regards to medication discussions with your patients.
Dr. Dadiomov serves as an expert in the field, frequently consulted and educating on best practices relating to psychotropic medications. Real-world clinical cases are used to supplement the material and reinforce complex topics into pertinent components. The most pressing, and frequently requested topics are presented including how to discuss the benefits and risks of medications within the scope of practice with your patients. The goal is for you to leave better prepared to communicate with your clients as well as the prescribers and other interdisciplinary colleagues. Dr. Dadiomov instructs you on how the medications work, their benefits, the side effects, and the most important information to optimize treatment outcomes.
All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners. For speaker disclosures, please see the faculty biography.
NOTE: Each purchase includes CE credit for one individual (participants in full attendance will be able to print the certificate of completion after passing the online post-test (80% passing score) and completing the evaluation). Instructional methods will include PowerPoint, didactic lecture, Q&A, and others.
Continuing Education Information: Credits listed below are for full attendance at the live, interactive webinar only. This webinar is being broadcast live in real-time and must be attended live, in its entirety, in order to earn credit. You will be able to type questions to the speaker. The speaker will see the questions and address them during the presentation as time allows. Please note, your licensing board dictates whether web-based activities are an acceptable form of continuing education, as well as which credit types are acceptable for continuing education hours. Please refer to your licensing board's rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact info@pesi.com or 800-844-8260 before the event.
Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.
For Planning Committee disclosures, please see the statement above. For speaker disclosures, please see the faculty biography.
Earn up to 6.25 CE hours. Please see below, for more details, as credit amounts vary by jurisdiction and profession.
THIS ACTIVITY QUALIFIES FOR 3.0 HOURS OF ETHICS INSTRUCTION. Not all boards allow ethics credit for on-line programs. If ethics is not specified within your licensing board’s approval statement below, please contact your board to determine the applicability and amount of ethics allowed.
PESI, Inc. is approved by the Canadian Counselling and Psychotherapy Association to offer continuing education for counsellors and psychotherapists. PESI, Inc. maintains responsibility for the program. This activity is approved for 6.0 credit hours.
PESI, Inc., #1062, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: January 27, 2023 - January 27, 2026. Social workers completing this course receive 6.25 total credits including 3.25 Clinical and 3.0 Ethics continuing education credits.
Course Level: Intermediate Format: Synchronous Distance. Full attendance is required; no partial credits will be offered for partial attendance.
Canadian Social Workers: Canadian provinces may accept activities approved by the ASWB for ongoing professional development.
PESI, Inc. is approved by the Canadian Psychological Association to offer continuing education for psychologists. PESI, Inc. maintains responsibility for the program. This program is approved for 6.0 continuing education hours. Full credit statement at: www.pesi.com/cpa-statement
This activity qualifies for 380 continuing education minutes as required by many national and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.
PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses in full attendance will earn 6.25 contact hours. Partial contact hours will be awarded for partial attendance.
David Dadiomov, PharmD, BCPP, is an assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy at the USC Mann School of Pharmacy and Pharmaceutical Sciences.
He holds board certification in psychiatric pharmacy and serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more. Dr. Dadiomov practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest of its kind in the United States.
Dr. Dadiomov’s teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. His expertise has been shared with experienced clinicians, graduate students and advanced level students. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching and clinical innovation and has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.
Speaker Disclosures:
Financial: Dr. David Dadiomov has employment relationships with the University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, the University of Southern California Psychiatry and Behavioral Sciences Medical Residency, and the Los Angeles County Department of Health Services. He receives a speaking honorarium and recording royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. David Dadiomov is a member of the American Society of Addiction Medicine, the College of Psychiatric and Neurologic Pharmacists, the American College of Clinical Pharmacy, the American Association of Colleges of Pharmacy, and the American Society of Health-System Pharmacists. He is a reviewer for several publications, for a complete list contact PESI.com.
For live CE credit, you must watch the live webcast in its entirety at its scheduled time and complete the CE quiz and evaluation within one week. You will have access for 90 days after the program for review.
Please note: There will be a 70-minute lunch and two 15-minute breaks; one in the morning and one in the afternoon. Lunch and break times will be announced by the speaker and at their discretion. A more detailed schedule is available upon request.
Visit our FAQ page at https://www.pesicanada.ca/faq or contact us at https://www.pesicanada.ca/contact-us.
MEDS 101
GENERAL OVERVIEW OF THE NERVOUS SYSTEM
DEPRESSION MEDICATIONS
ANXIETY DISORDER MEDICATIONS
BIPOLAR MEDICATIONS
ADHD MEDICATIONS
ANTIPSYCHOTIC MEDICATIONS
INSOMNIA MEDICATIONS
LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to info@pesicanada.com.
Please wait ...
